[ Price : $8.95]
FDA accepts for review an Achieve Life Sciences NDA for cytisinicline, an investigational treatment for helping those seeking to q...[ Price : $8.95]
Reuters reports that drug manufacturers are turning to artificial intelligence to reduce animal testing and cut costs and time in ...[ Price : $8.95]
FDA warns Castle Rock, CO-based Compounders International Analytical Laboratory about CGMP violations and deviations in its work t...[ Price : $8.95]
FDA publishes the 2025 OTC drug monograph forecast showing eight items it expects to address over the next three years.[ Price : $8.95]
FDA approves two new denosumab biosimilars from Shanghai Henlius Biotech and Organon for treating osteoporosis and cancer-related ...[ Price : $8.95]
Merck says its oral PCSK9 inhibitor met all primary and secondary endpoints in the CORALreef Lipids Phase 3 trial.[ Price : $8.95]
FDA releases the form FDA-483 with four observations from an inspection at the Las Vegas, NV-based AnazaoHealth compounding facili...[ Price : $8.95]
FDA policy and regulatory expert Steven Grossman warns that the agencys current trajectory risks undermining its effectiveness by ...